Premier Pharmacy Labs Buprenorphine HCL INJ Preserved

Recall announced June 17, 2019 by Premier Pharmacy Labs Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance. The agency has closed this recall.

Where sold
Nationwide.
Last updated
November 19, 2026

Products included

Read the official notice. Always compare the codes on your package with the official notice. It is the final word.

Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.

See all pet recalls